Loading...
  • Prevalence
  • Although the number of samples in this study was limited and might not represent the overall incidence and prevalence in Thai women, but the baseline data are of interest and suggest further study for primary cancer screening and/or developing the efficiency of prophylactic HPV vaccines in Thailand. (koreascience.or.kr)
  • As observed in other immunocompromised individuals with selective or combined T cell deficits, the prevalence and morbidity of human papillomavirus (HPV)-related disease is increased in patients with idiopathic CD4 T cell lymphocytopenia (ICL). (clinicaltrials.gov)
  • Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S et al (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. (springer.com)
  • Franceschi S, Herrero R, Clifford GM, Snijders PJ, Arslan A, Anh PT et al (2006) Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. (springer.com)
  • In women, the prevalence of the different genotypes of HPV has been determined and analyzed within the setting of cytologic examinations with the purpose of screening for and diagnosing precancerous and cancerous lesions. (biomedcentral.com)
  • doses
  • Participants received 3 doses of the HPV vaccine (Cervarix, GlaxoSmithKline Biologicals) in a 0, 1, 6 month schedule. (jrheum.org)
  • In this patient, HPV16-specific antibody concentrations were also low after 3 vaccine doses (9.1 LU/ml). (jrheum.org)
  • The kinetics of the antibody response differed from controls, with no responses after the first 2 vaccine doses in patients with SLE and low responses after the third dose in patients with JDM. (jrheum.org)
  • Participants will get 3 doses of the study vaccine over 6 months as a shot in the upper arm or thigh muscle. (clinicaltrials.gov)
  • The participants will receive two doses of the vaccine at Day 1 and Day 180. (clinicaltrials.gov)
  • The participants will be randomly allocated in equal numbers to receive either two or three doses of the vaccine. (clinicaltrials.gov)
  • dose
  • The vaccine is routinely given to girls as a multiple dose series between the ages of 11-12 years (though it may be used starting at age 9). (portsmouthhospital.com)
  • All patients and controls were seropositive for HPV16 and 18 after the third vaccine dose, except for 1 patient with JDM who was seronegative for HPV18 after initial low HPV18-specific antibody concentrations (20.5 LU/ml) at 3 months. (jrheum.org)
  • Girls in the two-dose group will receive the vaccine at Day 1 and Day 180, girls in the three-dose group will receive the vaccine at Day 1, Day 60, and Day 180. (clinicaltrials.gov)
  • Vaccine dose administered is obtained from manufacturing Lot 1. (clinicaltrials.gov)
  • The time to onset after the first vaccine dose ranged from 1 to 1532 days (average 319.7 ± 349.3 days). (springer.com)
  • The time to onset after the first vaccine dose showed a wide range (average 319.7 ± 349.3 days). (springer.com)
  • precursor
  • Of importance, studies in each of these sites have shown the feasibility of visual inspection and specimen collection for cytologic and histologic examination of the presence of dysplasia, as well as the ability to treat precursor lesions ( Table 1 ). (aacrjournals.org)
  • disease
  • Sadly, despite widespread screening and treatment of pre-invasive lesions, there are still approximately 12,000 new cases of cervical cancer in the United States each year and roughly 4,000 annual deaths from the disease. (medscape.com)
  • Women with HPV-related disease were younger than women with HPV-negative lesions. (aafp.org)
  • Screening programs in industrialized countries have drastically reduced the incidence and mortality of cervical cancer, and research in the last decades has greatly improved our capability to detect the etiologic viral component of the disease, human papillomavirus (HPV), and contributed to a decrease in rates of progression to cervical cancer. (biomedcentral.com)
  • invasive
  • Well-differentiated lesions tend to spread along the surface with minimal invasion, whereas anaplastic lesions are more likely to be deeply invasive. (cancer.gov)
  • specimens
  • To study the feasibility of self-collected specimens for testing human papillomavirus (HPV) status among hard-to-reach women, outreach nurses recruited women in women's centres, shelters and alleys in Vancouver's Downtown Eastside. (cmaj.ca)
  • Analogous studies of the presence of an HPV-induced oropharyngeal precancerous lesion, or a method to collect specimens for identifying such a lesion, have been lacking. (aacrjournals.org)